Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acutelines: a Large Biobank Aiming to Improve Early Recognition of Acute Diseases, Contribute to the Development of Personalized Medicine and Optimize Short- and Long-term Outcome

NCT04615065 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04615065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acutelines: a Large Biobank Aiming to Improve Early Recognition of Acute Diseases, Contribute to the Development of Personalized Medicine and Optimize Short- and Long-term Outcome
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2020
Completion date
September 1, 2030
Enrollment
35,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute disease, acute kidney injury, anaphylaxis, complication of treatment, dyspnea, electrolyte disturbance, emergencies, frailty, hemorrhage, intoxication by drug, pneumonia, polypharmacy, pulmonary embolism, sepsis, shock, skin infection, syncope, thrombosis, urinary tract infections